/PRNewswire/ – Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that David E.I. Pyott, a member of the company’s Board of Directors, has submitted his resignation, effective today, in order to devote more time to his role as chairman and chief executive officer of Allergan, Inc.
“The board and I are truly appreciative of David’s service and commitment to Edwards during the last 14 years,” said Michael A. Mussallem, Edwards’ chairman and CEO. “David’s extensive global experience in leadership roles at innovative health and nutrition companies made him a valuable resource for our company. He has been a trusted partner and brought important expertise to Edwards in delivering novel therapies to address the needs of patients. We wish him the best and thank him for the significant role he has played in Edwards’ growth and success.”
Pyott joined Edwards’ board of directors in 2000, when Edwards was established as an independent, publicly-held corporation.
Source: Edwards Lifesciences Corporation